Skip to content

Author

Heejung Ha

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Osteoprotegerin lowers type 2 diabetes risk: insights from drug-target Mendelian randomization and mediation analysis

Observational evidence suggests that denosumab, which acts through a mechanism partially analogous to that of the endogenous protein osteoprotegerin (OPG), may be associated with a lower risk of type 2 diabetes (T2D). This raises the possibility that modulation of the OPG pathway may influence diabetes risk. We a...

Heejung Ha, Wooin Lee, Yi-Jin An et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.